Rosiglitazone , Metformin or both for Treatment of Polycystic Ovary Syndrome
This study was designed to show the advantages of using the combination of metformin and rosiglitazone over using each drug alone in treatment of women with polycystic ovary syndrome (PCOS).Forty four women with PCOS were classified into 3 groups , group 1 received rosiglitazone (4mg/day) for 3 mont...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
College of Pharmacy University of Baghdad
2017-03-01
|
| Sarja: | Iraqi Journal of Pharmaceutical Sciences |
| Linkit: | https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/570 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|